| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |